{"id":508787,"date":"2021-07-01T08:08:02","date_gmt":"2021-07-01T12:08:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/"},"modified":"2021-07-01T08:08:02","modified_gmt":"2021-07-01T12:08:02","slug":"agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/","title":{"rendered":"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021"},"content":{"rendered":"<h2>\nLive Conference Call and Webcast at\u00a04:30 p.m. EDT<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">PRINCETON, N.J., July  01, 2021  (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women\u2019s healthcare company, today announced it will report second quarter 2021 financial results after the market close on\u00a0Monday, July 26, 2021 as follows:<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: bottom\">Date<\/td>\n<td style=\"vertical-align: bottom\">Monday, July 26, 2021<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Time<\/td>\n<td style=\"vertical-align: bottom\">4:30 p.m. EDT<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Webcast (live and archived)<\/td>\n<td style=\"vertical-align: bottom\">\n            <a href=\"https:\/\/ir.agiletherapeutics.com\/events-and-presentations\/\" rel=\"nofollow noopener\" target=\"_blank\">Events &amp; Presentations<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Dial-in numbers<\/td>\n<td style=\"vertical-align: bottom\">(833) 979-2857 (U.S. toll-free) or (236) 714-2948<\/td>\n<\/tr>\n<tr>\n<td style=\"vertical-align: bottom\">Conference ID<\/td>\n<td style=\"vertical-align: bottom\">1732729<\/td>\n<\/tr>\n<\/table>\n<p>Investors interested in listening to the conference call may do so by dialing (833) 979-2857 for domestic callers or (236) 714-2948 for international callers. A live webcast will be available in the Events and Presentations section of the Investor Relations page at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BbGbBJAUJ6H5XA07QVy3IgwAzwDyBGmHIj0eCMU-PTMeDCQHmt-l1-lFd3cKOj_0Uir2YVRA-8zBrDIUX1wEU1qwhxdJUFb6RlInU8K4CND9AM4LNxLqaVJ8ASFC4NDSsP0gWqqHLzSZpYxww2z86geqxrbNWY8ocjh4aKBxlet3RaCg_VHGBxKrBPOhKWgx\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/ir.agiletherapeutics.com\/events-and-presentations\/<\/a>, or by <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=E5zRXi1CWbYlS7dm1ueHm3Ek_5U4bbfjI-jl70kZHQM0i_RTPoxKxoNnYBS2RXUnccNp9oAVkcOZvn9mG5ZPM7XaDLwu1vWjwpVd0DQsBbjNd0VME2GySFa16AfCEnEJ4YtTq5XdOOYsna9PPn2BTriN4c44bLMTeTs7TRwa438zso4tEGWRSI8JhPDXIbwvfOSnKtzsStslVZWtooUVjapkYMJrSXytnQdjsVKKmww8XKk_FZvLRIgB70shxgknSrls6agVfDi-y9-6tLuzzw==\" rel=\"nofollow noopener\" target=\"_blank\">clicking here<\/a>.<br \/>Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the company&#8217;s website.<\/p>\n<p>\n        <strong>About\u00a0Agile Therapeutics, Inc.<\/strong><br \/>\n        <br \/>Agile Therapeutics\u00a0is a forward-looking women&#8217;s healthcare company dedicated to fulfilling the unmet health needs of today\u2019s women.\u00a0Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method.\u00a0Our initial product, Twirla\u00ae, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion\u00ae, which is designed to allow drug delivery through the skin. For more information, please visit the company website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=uMEYCPr6e81CPVgqfE4SyAx4Vs3cKscYjvGC6cC5nn8pvcVPivMgemrojGAfwRJ1EgFinExf3y0fJIUDkXelI3HJS9wQ5AXPujC26Pj9yRL_UADfauFCIgGC8PbQYvtdQOu5E4NLt1l0apG-eMbvn2hNKD72cQYzbiNlPo9bouStL7wGHGH_mx02-KjXz-cMN9xMbVo_EWSQ9TDdIvo5mmmeVqYNoPfk9ZJcAcUAizkDfJeRB4dMjFCDSFF37SKrdMSZUY2dwjntIU_0XzqQvNTufmKbTbIJf4wGJR70_FwaEElIecXsDyOcNXbydGVP-TjYNex2aBaGBJvJg4gSV0Js-EImeDGP-LTj21zhOPnk9BnzQOlHpuQ2xm-9vnUr6WC9mypTXcU-lFZ_GidhyzLzsT0EwM4xlZmr0kLklBY0Mr5Y3vAUsJgjGNMwfKjI5BHMTPmLDYVnafC_rq7SFhB6Z8HIZulMMPbU2mi5qFjl3nHewALitsYvDNvwOk4j2WlMXatkiGmYiuVBsHn0Pg==\" rel=\"nofollow noopener\" target=\"_blank\"><strong>www.agiletherapeutics.com<\/strong><\/a>. The Company may occasionally disseminate material, nonpublic information on the Company\u2019s website.<\/p>\n<p>\n        <strong>Contact:<\/strong>\u00a0<br \/>Matt Riley<br \/>Head of Investor Relations &amp; Corporate Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0EvBhRSKDRaC7kjv10Y7HP8X8AauNVEzh2Rc_9sZSBmgO-QzyNm62HNrZXvCrfmWps7v6cOvkC_bcAfoUJ88KL0H-_B3TYeGTi_sltjNkn3fww0G6Nkc4w7_IY7j67ZalpJ__1UsgYyp6fTkMdfEGL2EFQ9PirUFZtV43yno9-tu9OlCIQThIW6S-HBe5N-5hs61NbR_2gnb05mb2MIYyHpo0DEF7NtoD2G4M4QGzV4aPm7SVk1ZImKgLizl-gmNVWuJ-u5f7bpZ0kZ8mlPVWBu2Riyh316xMHncKVOKqPU=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>mriley@agiletherapeutics.com<\/strong><\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/fc2aaa24-56b6-4264-b6b1-3e6db3bf84b9\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Live Conference Call and Webcast at\u00a04:30 p.m. EDT PRINCETON, N.J., July 01, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women\u2019s healthcare company, today announced it will report second quarter 2021 financial results after the market close on\u00a0Monday, July 26, 2021 as follows: Date Monday, July 26, 2021 Time 4:30 p.m. EDT Webcast (live and archived) Events &amp; Presentations Dial-in numbers (833) 979-2857 (U.S. toll-free) or (236) 714-2948 Conference ID 1732729 Investors interested in listening to the conference call may do so by dialing (833) 979-2857 for domestic callers or (236) 714-2948 for international callers. A live webcast will be available in the Events and Presentations section of the Investor Relations page at https:\/\/ir.agiletherapeutics.com\/events-and-presentations\/, or by clicking here.Please log &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-508787","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Live Conference Call and Webcast at\u00a04:30 p.m. EDT PRINCETON, N.J., July 01, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women\u2019s healthcare company, today announced it will report second quarter 2021 financial results after the market close on\u00a0Monday, July 26, 2021 as follows: Date Monday, July 26, 2021 Time 4:30 p.m. EDT Webcast (live and archived) Events &amp; Presentations Dial-in numbers (833) 979-2857 (U.S. toll-free) or (236) 714-2948 Conference ID 1732729 Investors interested in listening to the conference call may do so by dialing (833) 979-2857 for domestic callers or (236) 714-2948 for international callers. A live webcast will be available in the Events and Presentations section of the Investor Relations page at https:\/\/ir.agiletherapeutics.com\/events-and-presentations\/, or by clicking here.Please log &hellip; Continue reading &quot;Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-07-01T12:08:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021\",\"datePublished\":\"2021-07-01T12:08:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/\"},\"wordCount\":283,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/\",\"name\":\"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=\",\"datePublished\":\"2021-07-01T12:08:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/","og_locale":"en_US","og_type":"article","og_title":"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021 - Market Newsdesk","og_description":"Live Conference Call and Webcast at\u00a04:30 p.m. EDT PRINCETON, N.J., July 01, 2021 (GLOBE NEWSWIRE) &#8212; Agile Therapeutics, Inc.\u00a0(Nasdaq: AGRX), a women\u2019s healthcare company, today announced it will report second quarter 2021 financial results after the market close on\u00a0Monday, July 26, 2021 as follows: Date Monday, July 26, 2021 Time 4:30 p.m. EDT Webcast (live and archived) Events &amp; Presentations Dial-in numbers (833) 979-2857 (U.S. toll-free) or (236) 714-2948 Conference ID 1732729 Investors interested in listening to the conference call may do so by dialing (833) 979-2857 for domestic callers or (236) 714-2948 for international callers. A live webcast will be available in the Events and Presentations section of the Investor Relations page at https:\/\/ir.agiletherapeutics.com\/events-and-presentations\/, or by clicking here.Please log &hellip; Continue reading \"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-07-01T12:08:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021","datePublished":"2021-07-01T12:08:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/"},"wordCount":283,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/","name":"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=","datePublished":"2021-07-01T12:08:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MzQzMiM0Mjc3NTcxIzIwMDc5MTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/agile-therapeutics-to-report-second-quarter-2021-financial-results-and-provide-business-update-on-monday-july-26-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Agile Therapeutics to Report Second Quarter 2021 Financial Results and Provide Business Update on Monday, July 26, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/508787","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=508787"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/508787\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=508787"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=508787"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=508787"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}